Cargando…

Comparative effectiveness of switching paroxetine formulation for treatment of major depressive disorder: an open-label multicenter study

AIM: To assess the effectiveness and safety of switching the antidepressant formulation from immediate-release (IR) to controlled-release (CR) paroxetine in patients with major depressive disorder (MDD). PATIENTS AND METHODS: A total of 113 outpatients with MDD diagnosed according to the Diagnostic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Otsubo, Tempei, Watanabe, Yoshinori, Hongo, Seiji, Inoue, Mikichika, Akimoto, Kimiko, Murakami, Ken, Takahashi, Ryutaro, Kikuchi, Toshiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896672/ https://www.ncbi.nlm.nih.gov/pubmed/29670356 http://dx.doi.org/10.2147/NDT.S152985

Ejemplares similares

Brexpiprazole for the Treatment of Schizophrenia in Adults: An Overview of Its Clinical Efficacy and Safety and a Psychiatrist’s Perspective
por: Watanabe, Yoshinori, et al.
Publicado: (2020)

Pharmacokinetics of immediate and sustained-release formulations of paroxetine: Population pharmacokinetic approach to guide paroxetine personalized therapy in chinese psychotic patients
por: Li, Xiao-lin, et al.
Publicado: (2022)

Paroxetine overdose
por: Gupta, Arun K., et al.
Publicado: (2005)

Antidepressant and Neuroprotective Effects of 3-Hydroxy Paroxetine, an Analog of Paroxetine in Rats
por: Hernández-Arrambide, Pedro Efraín, et al.
Publicado: (2022)

Development and acceptability of a decision aid for anxiety disorder considering discontinuation of benzodiazepine anxiolytic
por: Aoki, Yumi, et al.
Publicado: (2023)

Paroxetine-induced galactorrhea
por: Gulati, Prannay, et al.
Publicado: (2014)

Paroxetine-induced galactorrhea
por: Petrykiv, S., et al.
Publicado: (2022)

Comparison Between Tadalafil Plus Paroxetine and Paroxetine Alone in the Treatment of Premature Ejaculation
por: Moudi, Emadouddin, et al.
Publicado: (2016)

Long-term efficacy and safety of lamotrigine for all types of bipolar disorder
por: Watanabe, Yoshinori, et al.
Publicado: (2017)

Paroxetine‐induced QTc prolongation
por: Otsuka, Yuji
Publicado: (2017)

Paroxetine overdose during pregnancy
por: Acar, Selin, et al.
Publicado: (2021)

Inclusion Scenarios and Conformational Flexibility of the SSRI Paroxetine as Perceived from Polymorphism of β-Cyclodextrin–Paroxetine Complex
por: Aree, Thammarat
Publicado: (2022)

Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder
por: Aoki, Akiko, et al.
Publicado: (2014)

Effectiveness of paroxetine in the treatment of poststroke depression
por: Ma, Chen, et al.
Publicado: (2018)

Paroxetine combined with olanzapine in the treatment of schizophrenia
por: Wang, Ning, et al.
Publicado: (2020)

Paroxetine—Overview of the Molecular Mechanisms of Action
por: Kowalska, Magdalena, et al.
Publicado: (2021)

Efficacy of cognitive behavioral therapy with paroxetine and paroxetine only for social anxiety disorder: A behavioral, placebo-controlled study
por: Samantray, Narendranath, et al.
Publicado: (2019)

Combination of valproate and paroxetine in mice exposed to picrotoxin
por: Kamal, Sahar M
Publicado: (2012)

Paroxetine in the treatment of recurrent brief depressive disorder
por: Prakash, Sathya, et al.
Publicado: (2013)

Mirtazapine in Paroxetine Induced Hyper-prolactinemic Galactorrhoea
por: Singh, Manjeet, et al.
Publicado: (2015)

Mechanism of Paroxetine (Paxil) Inhibition of the Serotonin Transporter
por: Davis, Bruce A., et al.
Publicado: (2016)

Critical appraisal of paroxetine for the treatment of vasomotor symptoms
por: Carroll, Dana G, et al.
Publicado: (2015)

Extra-Paramidal Side Effects Associated with Paroxetine
por: Nicholson, Simon D.
Publicado: (1992)

Successful Use of Risperidone, Trihexyphenidyl, and Paroxetine in Pregnancy
por: Goyal, Sandeep Kumar, et al.
Publicado: (2017)

Euprolactinemic Galactorrhea with Paroxetine: Exploring the Missing Link
por: Mishra, Shree, et al.
Publicado: (2019)

Musical Hallucinations Induced by Conventional Doses of Paroxetine
por: Muraosa, Haruka, et al.
Publicado: (2020)

The Antidepressant Paroxetine Reduces the Cardiac Sodium Current
por: Plijter, Ingmar S., et al.
Publicado: (2023)

New validated HPLC methodology for the determination of (−)-trans-paroxetine and its enantiomer in pharmaceutical formulations with use of ovomucoid chiral stationary phase
por: Lisowska-Kuźmicz, Małgorzata, et al.
Publicado: (2014)

Factors Associated with Non-Remission in Bipolar Disorder: The Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI)
por: Tsuboi, Takashi, et al.
Publicado: (2020)

Effect of high-dose milnacipran in patients with depression
por: Hayashi, Masatoshi, et al.
Publicado: (2007)

Comparison of Tolerance of Venlafaxine, Paroxetine and Amitriptyline in Depression Therapy
por: Miskovic, Mirjana
Publicado: (2015)

Blockade of Kv1.5 by paroxetine, an antidepressant drug
por: Lee, Hyang Mi, et al.
Publicado: (2016)

The influence of paroxetine on the pharmacokinetics of atomoxetine and its main metabolite
por: TODOR, IOANA, et al.
Publicado: (2015)

Total Synthesis of (±)-Paroxetine by Diastereoconvergent Cobalt-Catalysed Arylation
por: Despiau, Carole F, et al.
Publicado: (2014)

Comparison of the Efficacy of Tramadol and Paroxetine in the Management of Premature Ejaculation
por: Ur Rehman, Muhammad Fazal, et al.
Publicado: (2020)

Effect of Paroxetine on the Neuropathic Pain: A Molecular Study
por: Zarei, Malek, et al.
Publicado: (2020)

Paroxetine Increases δ Opioid Responsiveness in Sensory Neurons
por: Brackley, Allison Doyle, et al.
Publicado: (2022)

Collapse-related traumatic intracranial hemorrhage following out-of-hospital cardiac arrest: A multicenter retrospective cohort study
por: Inoue, Fumiya, et al.
Publicado: (2023)

Switching Antipsychotics to Blonanserin in Patients with Schizophrenia: An Open-label, Prospective, Multicenter Study
por: Woo, Young Sup, et al.
Publicado: (2019)

Does cognitive behavioral therapy for anxiety disorders assist the discontinuation of benzodiazepines among patients with anxiety disorders? A systematic review and meta‐analysis
por: Takeshima, Masahiro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7ss24ouo8jqkl491j4ca13o92l